Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore various ways to get quick cash today. These strategies will help you access funds when you need them most.
23,336 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As markets digest a high-stakes political address and evolving risk appetite, bitcoin nudges higher. Traders balance ...
Nio stunned investors with its first quarterly net profit, driving a sharp rally on a market day shaped by mixed indi...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
If you’re chasing reliable income from utilities, you’ll want a clear read on Duke Energy versus Dominion Energy. Thi...
Investors are weighing whether lululemon stocks stage turnaround is still on the table. This guide breaks down the fa...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
Brace yourself for a clear, investor-friendly read on chord energy (chrd) 2025 Q4 results. This deep dive breaks down...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
Two drone-focused names—Red Cat Holdings and Unusual Machines—face off for investors. This guide breaks down the mark...
This in depth review breaks down the lien 2026 earnings transcript in plain language. You’ll see what the numbers mea...
Two heavyweight contenders face off in the market: a mature e-commerce and cloud leader, and a high-flying space inno...